<DOC>
	<DOCNO>NCT01117753</DOCNO>
	<brief_summary>Adolescent substance abuse result significant negative outcome extraordinary cost youth , family , community , society . Moreover , rate psychiatric comorbidity among substance abuse youth range 25 % 82 % , youths dual diagnosis twice costly treat compare comorbidity . The applicant principal investigator recently complete pilot project fund National Institute Drug Abuse focus develop pilot psychosocial treatment specifically youth present outpatient treatment co-occurring substance use internalizing ( i.e. , mood and/or anxiety ) problem . Results promise experimental group exhibit significantly less substance use rapid reduction anxiety depressive symptom compare control group . The propose research randomize clinical trial ( RCT ) compare experimental treatment ( OutPatient Treatment Adolescents ; OPT-A ) `` active placebo '' key clinical index pre-treatment 18 month . The propose RCT ( n = 160 ) employ treatment manual , quality assurance protocol , therapist training protocol develop successfully test pilot study , evaluate efficacy OPT-A youth refer outpatient treatment co-occurring substance use internalize problem . The following outcome evaluate : drug use ; mental health ; behavioral , school , peer , family functioning ; consumer satisfaction . The intervention address one prevalent challenging , costly , understudied presenting problem among adolescent outpatient . If successful , research could provide considerable contribution treatment field youth co-occurring substance use internalize disorder .</brief_summary>
	<brief_title>Research Outpatient Adolescent Treatment Comorbid Substance Use Internalizing Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<criteria>10 17 year age Residing least one adult caregiver serve parent figure In need treatment Substance Abuse Dependence Disorder In need treatment Axis I Mood Disorder and/or Anxiety Disorder Pervasive Developmental Disorder Active Psychotic Disorder Severe profound mental retardation</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>